Reports for TEVA-SUCRALFATE
Brand name
TEVA-SUCRALFATE
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02045702 |
Ingredients
SUCRALFATE |
Ingredient Strength
1 G |
ATC Code
A02BXA02BX |
ATC Descriptor
DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| TEVA-SUCRALFATE | 500 | Resolved | 2024-08-30 | 2024-11-08 | 236362 |
| TEVA-SUCRALFATE | 100's | Resolved | 2025-05-05 | 2025-09-02 | 256702 |
| TEVA-SUCRALFATE | 500 | Resolved | 2025-08-08 | 2025-09-02 | 264778 |
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| TEVA-SUCRALFATE | ALL (100's and 500's) | Discontinued | 2025-09-02 | 2025-09-02 | 266359 |
Showing 1 to 1 of 1